New Topical PDE4 Inhibitor Gets FDA Green Light for Chronic Skin Disease

0 0 Less than a minute

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

New Topical PDE4 Inhibitor Gets FDA Green Light for Chronic Skin Disease (MedPage Today) — The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for mild/moderate atopic dermatitis (AD).
The approval allows for use in adults and pediatric patients at least 2 years…